Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Elective Surgery in Adults

PHASE4CompletedINTERVENTIONAL

Enrollment

650

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

March 30, 2025

Study Completion Date

May 31, 2025

Conditions

Hypotension During Surgery

Interventions

DRUG

Remimazolam Tosilate for Injection 0.1mg/kg

Remimazolam Tosilate for Injection 0.1mg/kg at induction

DRUG

Remimazolam Tosilate for Injection 0.15mg/kg

Remimazolam Tosilate for Injection 0.15mg/kg at induction

DRUG

Remimazolam Tosilate for Injection 0.2mg/kg

Remimazolam Tosilate for Injection 0.2mg/kg at induction

Trial Locations (1)

TongjiHospital, Wuhan

All Listed Sponsors

lead

Tongji Hospital

OTHER